Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Intestinal involvement in graft versus host disease in children : an overview by the ESPGHAN Gastroenterology Committee
Authors:ID Vincent, Marina (Author)
ID Assa, Amit (Author)
ID Borrelli, Osvaldo (Author)
ID Homan, Matjaž (Author)
ID Martin-de-Carpi, Javier (Author)
ID Mišak, Zrinjka (Author)
ID Puoti, Maria Giovanna (Author)
ID Scheers, Isabelle (Author)
ID Sila, Sara (Author)
ID Strisciuglio, Caterina (Author)
ID Tzivinikos, Christos (Author)
ID Dolinšek, Jernej (Author)
ID Mas, Emmanuel (Author)
Files:.pdf PDF - Presentation file, download (770,51 KB)
MD5: 082C107B5596F525C6A2E110572FEB16
 
URL URL - Source URL, visit https://onlinelibrary.wiley.com/doi/10.1002/jpn3.70087
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Graft versus host disease (GVHD) is a complication that frequently occurs afterhaematopoietic stem cell transplantation and concerns many children in paediatrichaematology‐oncology and bone marrow transplantation departments. It can affectvarious organs, with the skin, gastrointestinal tract and liver being the most com-monly involved. To confirm intestinal GVHD and to rule out differential diagnosesendoscopy is frequently needed. Currently, there are no specific consensus rec-ommendations concerning the best method for endoscopic exploration and medicalmanagement of this disease in children, with limited studies available, including alow number of patients. Sigmoidoscopy could be initially proposed under sedation. Ifsigmoidoscopy is normal or if a general anaesthesia is required, colonoscopy andupper endoscopy should be planned, avoiding duodenal biopsy because of the riskof duodenal haematoma. Regarding therapeutic options, corticosteroids are thefirst‐line treatment for GVHD. Ruxolitinib, a Janus kinase inhibitor, is indicated forchildren aged 12 years and older with acute or chronic GVHD who have aninadequate response to corticosteroids or other systemic therapies. Nutritionalsupport has a key role in the management of intestinal GVHD and should beconsidered to guarantee the best possible evolution of intestinal GVHD.
Keywords:GVHD, children, complication, endoscopy, haematopoietic stem cell transplantation, intestine
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 246–255
Numbering:Vol. 81, iss 2
PID:20.500.12556/DiRROS-24121 New window
UDC:616-053.2
ISSN on article:1536-4801
DOI:doi.org/10.1002/jpn3.70087 New window
COBISS.SI-ID:237958403 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 2. 6. 2025;
Publication date in DiRROS:14.11.2025
Views:126
Downloads:56
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of pediatric gastroenterology and nutrition
Shortened title:J. pediatr. gastroenterol. nutr.
Publisher:Lippincott Williams & Wilkins
ISSN:1536-4801
COBISS.SI-ID:3611412 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back